Buscar resultados de ensayos clínicos

Patrocinado por

Fallopian Tube Diseases - 17 Studies Found

Estado Estudiar
Completed Nombre del estudio: LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer
Condición:
  • Epithelial Ovarian Cancer
  • Peritoneal Cancer
  • Fallopian Tube
    Fecha: 2016-01-21
    Intervenciones: Other: Diagnostic analysis Molecular profiling
Active, not recruiting Nombre del estudio: A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
Condición:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Ca
    Fecha: 2016-01-20
    Intervenciones:
    • Drug: Paclitaxel Please see ar
Completed Nombre del estudio: A Study of Long-Term Responders on Olaparib
Condición:
  • Epithelial Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal
    Fecha: 2015-04-24
Not yet recruiting Nombre del estudio: A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
Condición:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Neoadjuvant Treatment
    Fecha: 2015-04-17
    Intervenciones:
    • Drug: Olaparib Other Name: Lyn
Active, not recruiting Nombre del estudio: Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
Condición:
  • Ovarian Cancer
  • Primary Peritoneal Cancer
  • Fallopian Tube Ca
    Fecha: 2014-04-22
    Intervenciones:
    • Drug: Paclitaxel,
    • Drug: Bevacizumab
Completed Nombre del estudio: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
Condición:
  • Advanced Epithelial Ovarian
  • Recurrent Epithelial Ovarian
  • F
    Fecha: 2013-10-25
    Intervenciones: Drug: Enzalutamide All enrolled patients will be treated with enzalutamide 160mg by mouth QD. Study drug
Completed Nombre del estudio: A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian
Condición: Primary Peritoneal Carcinoma
Fecha: 2013-09-18
Intervenciones:
  • Drug: Demcizumab administered

<<< Previous